Author's posts
A New Targeted Cancer Company To Watch
Jean Cui led the invention of Pfizer’s Xalkori. Now she has her own company focusing on drug-resistant cancers, and it has raised $147 million.
Researchers Behind Spinraza Win Breakthrough Prize
“It is a breakthrough to be able to make progress in an area like this. I think that is something that is really worth celebrating.”
How Paul Allen Taught Me To Peel An Orange
“Paul, Paul, slow down. I’ve spent my whole lifetime studying the brain, and not in my lifetime, and probably not in your lifetime will we understand how the brain works.”
A Preview Of The 2018 Forbes Healthcare Summit
The Forbes Healthcare Summit will convene in New York on November 28 and 29, gathering executives, investors, researchers and patients to imagine the healthcare system as it should be.
Sarepta Gene Therapy Appears To Help Fourth Boy With Duchenne Muscular Dystrophy
“The cautionary note is this all has to be confirmed in a larger trial,” says Douglas Ingram, Sarepta’s president and chief executive. “Our goal is to bring this therapy rapidly to patients around the world,” Ingram says.
CRISPR-Based Drugmaker Raises $80 Million
KSQ Therapeutics, a Cambridge, Mass.-based biotechnology that uses the genetic-engineering tool CRISPR to develop new drugs, has raised $80 million, it’s second big raise in as many years. KSQ raised $76 million last October.
Alnylam Posts Positive Data On Second Drug, Plans FDA Meeting
Alnylam Pharmaceuticals says that its latest experimental drug was successful in a clinical trial, and hopes to ask the Food and Drug Administration to approve the medicine based on that data.
Aiming To Revolutionize Medical Ultrasound, Butterfly Raises $250 Million At A $1.25 Billion Valuation
The flood of cash represents a victory swashbuckling biotech entrepreneur Jonathan Rothberg who aims to change medical imaging with his $2,000 device. Investors include Fidelity, The Bill & Melinda Gates Foundation, and Fosun Pharma.
Paralyzed Patients Go From Wheelchairs To Walkers With Experimental Treatment
Two different groups of researchers have shown that electrical stimulation of the spinal cord, combined with months of intense training, can allow some people who have been paralyzed to regain some walking ability.
In Blowout, Amarin’s Fish-Oil-Derived Drug Dramatically Cuts Heart Risk In Study
The results, if they hold up, are likely to result in many patients getting the medicine, and could upend decades of orthodoxy among cardiologists.
